Pergolide and bromocriptine for the treatment of patients with hyperprolactinemia
- 1 February 1986
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 154 (2) , 431-435
- https://doi.org/10.1016/0002-9378(86)90685-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Dynamics of human chorionic gonadotropin, prolactin, and growth hormone in serum and amniotic fluid throughout normal human pregnancyAmerican Journal of Obstetrics and Gynecology, 1985
- Management of patients with hyperprolactinemia and normal or abnormal tomogramsAmerican Journal of Obstetrics and Gynecology, 1983
- Pergolide for the Treatment of Pituitary Tumors Secreting Prolactin or Growth HormoneNew England Journal of Medicine, 1983
- Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: a multicenter studyFertility and Sterility, 1983
- Size Reduction of Macroprolactinomas by Bromocriptine or Lisuride Treatment*Journal of Clinical Endocrinology & Metabolism, 1981
- Dopaminergic control of sympathetic tone and blood pressure: evidence in primary hypertension.Hypertension, 1980
- Pergolide Mesylate: A Potent Day-Long Inhibitor of Prolactin in Rhesus Monkeys and Patients with Parkinson's Disease*Journal of Clinical Endocrinology & Metabolism, 1980
- Bromocriptine inhibits norepinephrine releaseClinical Pharmacology & Therapeutics, 1979
- Galactorrhea: A Study of 235 Cases, Including 48 with Pituitary TumorsNew England Journal of Medicine, 1977
- Classification of Secondary Amenorrhea Based on Distinct Hormonal PatternsJournal of Clinical Endocrinology & Metabolism, 1975